Clinical Trials Browser

Phase 2 × Glioblastoma × durvalumab × Clear all

NCT02336165 2022-10-12

Phase 2 Study of Durvalumab (MEDI4736) in Patients With Glioblastoma

Phase 2 Completed

159 enrolled 23 charts

Glioblastoma

NCT02794883 2022-04-18

Tremelimumab and Durvalumab in Combination or Alone in Treating Patients With Recurrent Malignant Glioma

Phase 2 Completed

36 enrolled 13 charts

Glioblastoma, Glioma